by How Many People Have Insomnia? Global and US Statistics
Insomnia is the most common sleep disorder worldwide. Approximately 30% of adults experience occasional insomnia symptoms, while 10% have chronic insomnia disorder — a clinical condition that persists for at least three months. Here is the comprehensive data on global and US prevalence.
A supportive, comfortable mattress is one of the most evidence-backed environmental interventions for insomnia. The Saatva Classic — tested for spinal alignment and pressure relief — comes with a full 365-night trial.
Affiliate disclosure: We may earn a commission at no extra cost to you.
Global Insomnia Prevalence
| Region | Insomnia Symptoms (Any) | Chronic Insomnia Disorder | Source |
|---|---|---|---|
| Global average | ~30% | ~10% | Morin et al., Sleep Medicine Reviews 2021 |
| United States | 30–35% | 10–12% | NIH / AASM |
| Europe (Western) | ~30% | ~8–10% | Sleep Medicine Reviews |
| Asia-Pacific | ~17–26% | ~6–9% | Various national surveys |
| Latin America | ~35–40% | ~10–13% | Ibero-American Sleep Society |
US Insomnia Statistics in Detail
| Metric | Value | Source |
|---|---|---|
| Adults with any insomnia symptoms | ~70 million | NIH/CDC |
| Adults with chronic insomnia disorder | ~25–30 million | AASM Clinical Guidelines |
| Annual medical visits for insomnia | ~5.5 million | NHIS 2022 |
| Annual cost of insomnia (US) | $63–100 billion | Daley et al., Sleep 2009 + updated estimates |
| Insomnia as primary diagnosis | ~10% of insomnia cases | ICSD-3 |
| Insomnia comorbid with other disorders | ~90% of cases | ICSD-3 |
Insomnia Prevalence by Demographic
| Group | Prevalence of Insomnia Symptoms | Key Factor |
|---|---|---|
| Women | ~40% | Hormonal fluctuations, anxiety comorbidity |
| Men | ~30% | Lower reporting / help-seeking rates |
| Ages 18–34 | ~18–22% | Stress, technology use |
| Ages 35–64 | ~30–35% | Career and family stressors peak |
| Ages 65+ | ~50–60% | Age-related sleep architecture changes |
| Pregnant women | ~75–80% | Physical discomfort, hormonal changes |
| Shift workers | ~60–80% | Circadian rhythm disruption |
| Adults with anxiety/depression | ~75–90% | Bidirectional relationship |
The COVID Insomnia Surge: Coronasomnia
The COVID-19 pandemic produced a documented global surge in insomnia rates, now termed "coronasomnia" in clinical literature.
- 37% increase in insomnia cases during COVID lockdowns (Lancet, 2021)
- 40% of healthcare workers developed insomnia during the pandemic (BMJ Open)
- Insomnia as a post-COVID long-haul symptom: approximately 35% of long COVID patients report ongoing sleep disturbance
- Meta-analysis of 44 studies found global insomnia prevalence increased from ~18% to ~27% during peak pandemic periods
Insomnia Trends Over Time
| Period | Global Insomnia Prevalence | Key Driver |
|---|---|---|
| Pre-2000 | ~17% | Baseline population rate |
| 2000–2010 | ~22% | Internet era, 24/7 work culture |
| 2010–2019 | ~28% | Smartphone + social media proliferation |
| 2020–2021 | ~35% | COVID-19 pandemic surge |
| 2023–2024 | ~30–33% | Partial recovery, but elevated baseline |
Insomnia Treatment: What the Data Says Works
- Cognitive Behavioral Therapy for Insomnia (CBT-I): 80% response rate, recommended first-line by AASM
- Sleep restriction therapy (part of CBT-I): 90% improvement in sleep efficiency within 4 weeks
- Pharmacotherapy (benzodiazepines): Effective short-term, not recommended long-term due to dependence risk
- Melatonin: Effective for circadian phase disorders, limited evidence for chronic insomnia
- Sleep environment optimization: Temperature (65–68F ideal), mattress comfort, and light reduction show significant effects in randomized trials
Internal Resources
- Sleep deprivation vs. insomnia — full statistics comparison
- Core sleep statistics for the US population
- Average hours of sleep by demographic
- Back pain and insomnia — the data overlap
Frequently Asked Questions
How many people in the world have insomnia?
An estimated 30–40% of adults globally experience insomnia symptoms in any given year. Of these, 10–15% meet clinical criteria for chronic insomnia disorder — representing approximately 800 million to 1 billion people worldwide.
Is insomnia more common now than it used to be?
Yes. Insomnia prevalence has increased significantly over the past two decades. A 2020 meta-analysis found that global insomnia rates increased from approximately 17% (pre-2000 studies) to 28% (post-2010 studies), with the COVID-19 pandemic creating a further documented spike.
What is the difference between insomnia and sleep deprivation?
Sleep deprivation means not getting enough sleep opportunity — working too late, having a new baby, etc. Insomnia specifically means having adequate opportunity to sleep but experiencing difficulty falling asleep, staying asleep, or waking too early, at least 3 nights per week.
Which demographics have the highest insomnia rates?
Women (40% vs. 30% for men), older adults (50–60% report insomnia symptoms), people with anxiety or depression (75–90% have comorbid insomnia), and shift workers (60–80%) have the highest documented insomnia prevalence.
What treatments are most effective for insomnia?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the gold-standard first-line treatment, with 80% response rates and durable effects. Sleep medications have faster onset but lower long-term efficacy. Sleep environment improvements — including mattress quality, temperature, and light reduction — are supported by clinical evidence as adjunctive interventions.
Insomnia often persists because of an uncomfortable sleep surface. The Saatva Classic provides the spinal support and pressure relief that allows your nervous system to relax fully. 365-night trial — no risk.
Affiliate disclosure: We may earn a commission at no extra cost to you.